Psychotropic drug change | Psychotropic user without a drug | No psychotropic medication use | P-value | |
---|---|---|---|---|
(n = 405) | change (n = 289) | (n = 157) | ||
Mean age (years, ± S.D.) | 87.4 ± 8.8 | 86.9 ± 8.5 | 87.1 ± 10.2 | 0.76 |
Female | 75.1 | 73.0 | 75.8 | 0.76 |
Cognition | ||||
Normal or mild impairment | 20.1 | 20.6 | 29.0 | |
Moderate impairment | 58.6 | 52.4 | 44.7 | |
Severe impairment | 21.3 | 27.1 | 26.3 | 0.03 |
Pain | ||||
None | 55.6 | 66.4 | 74.5 | |
Mild | 26.4 | 22.0 | 13.1 | |
Moderate to severe | 18.0 | 11.6 | 12.4 | <0.001 |
Depression | ||||
None | 41.4 | 60.5 | 74.2 | |
Mild to moderate | 26.3 | 20.7 | 15.9 | |
Severe | 32.3 | 18.8 | 9.9 | <0.001 |
Fallers during 1 year follow-up | ||||
1 fall | 23.5 | 18.7 | 13.4 | |
≥ 2 falls | 41.0 | 22.5 | 12.1 | <0.001 |
Rate of falls during 1 year follow-up (per 1,000 person-days) | 7.6 | 4.1 | 2.0 | <0.001 |
Mean follow-up (days, ± S.D.) | 268 ± 121 | 258 ± 136 | 255 ± 132 | 0.47 |